Machine learning-driven identification of a ubiquitination-related prognostic signature and potential target NRDP1 in bladder cancer
A machine learning-based ubiquitination-related prognosis-associated signature showed superior performance over conventional clinical predictors, enabling accurate stratification of BCa patients into high- and low-risk subgroups, and highlights the value of integrating machine learning and ubiquitination biology.